文献
J-GLOBAL ID:201802240703497937
整理番号:18A0621826
肉腫様腎細胞癌におけるカペシタビン,ゲムシタビンおよびベバシズマブの第2相試験【Powered by NICT】
Phase 2 Trial of Capecitabine, Gemcitabine, and Bevacizumab in Sarcomatoid Renal-Cell Carcinoma
著者 (7件):
Maiti Abhishek
(Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, TX)
,
Nemati-Shafaee Maryam
(Department of Breast Medical Oncology, Baylor College of Medicine, Houston, TX)
,
Msaouel Pavlos
(Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX)
,
Pagliaro Lance C.
(Department of Oncology, Mayo Clinic, Rochester, MN)
,
Jonasch Eric
(Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX)
,
Tannir Nizar M.
(Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX)
,
Shah Amishi Y.
(Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX)
資料名:
Clinical Genitourinary Cancer
(Clinical Genitourinary Cancer)
巻:
16
号:
1
ページ:
e47-e57
発行年:
2018年
JST資料番号:
W3244A
ISSN:
1558-7673
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)